Topic

Articles

The fear of exposure to SARS-CoV-2 in healthcare settings has deterred people from seeking care for non-COVID-19 diseases. One solution to patient care and biomedical research disruptions is implementing remote solutions for conducting research and collecting samples.

Pandemic-Proof Clinical Study Start-Up

Recent case study highlights the importance of applying statistical rigor throughout the development and validation processes of biomarkers.

Integration of Biomarker Validation in Oncology Trials

Distinguishing CAR-T and CPI approaches and the clinical trial challenges and complexities associated with each.

Immunomodulators and Cancer Research

A look at one company’s platform approach in enabling the engineering of T-cells to identify and destroy cancer.

Designing Cell Therapies to Target Solid Tumors

SynteractHCR and The GOG Foundation Work Together Supporting Gynecologic Oncology Research

Cancer's R&D Convergence will highlight the changing landscape for clinical trials in this therapeutic area based on the promise of the Cancer MoonShot initiative, along with new oncology immunotherapies.

Cancer's R&D Convergence

The war on cancer has seen significant strides made in the search for a cure, however, recent data suggests that the work is far from over.

Cancer Moonshot 2020: Next Generation Standard of Care for Cancer

How to meet the rigorous safety and efficacy demands critical to evaluating newer targeted cancer therapies.

Overcoming Early Phase Oncology Challenges

Schulman IRB Selected as National IRB for Cancer MoonShot 2020 Initiative

The Cantrixil Phase I study will be weighted towards ovarian cancer patients with the selection of a gynecological oncology site.